100 related articles for article (PubMed ID: 3731034)
21. Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer.
Sarkar SK; Patra NB; Goswami J; Basu S
J Laryngol Otol; 2008 Feb; 122(2):188-92. PubMed ID: 17445333
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
González-Larriba JL; Garcia Carbonero I; Sastre Valera J; Perez Segura P; Diaz-Rubio E
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):90-7. PubMed ID: 9348577
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
[TBL] [Abstract][Full Text] [Related]
24. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
[TBL] [Abstract][Full Text] [Related]
27. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
Gonzalez MF; Valdivieso JG; Sartiano GP
Oncology; 1984; 41(6):377-82. PubMed ID: 6209601
[TBL] [Abstract][Full Text] [Related]
28. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
Amrein PC; Weitzman SA
J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
[TBL] [Abstract][Full Text] [Related]
29. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
[TBL] [Abstract][Full Text] [Related]
30. Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Kamnerdsupaphon P; Chitapanarux I; Lorvidhaya V; Sumitsawan Y; Tharavichitkul E; Sukthomya V
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1869-73. PubMed ID: 19011334
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
Zaheer S; Siddiqui SA; Akram M; Hasan SA
Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
[TBL] [Abstract][Full Text] [Related]
32. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
[TBL] [Abstract][Full Text] [Related]
33. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
[TBL] [Abstract][Full Text] [Related]
34. Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.
Merlano M; Tatarek R; Grimaldi A; Margarino G; Rosso R
Cancer Treat Rep; 1985 Sep; 69(9):961-4. PubMed ID: 4040809
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS
J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
39. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
Kim HS; Kim HR; Kim GM; Kim HS; Koh YW; Kim SH; Choi EC; Hong YK; Sung JH; Kim SM; Kim JH; Cho BC
Cancer Chemother Pharmacol; 2012 Oct; 70(4):539-46. PubMed ID: 22868340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
